This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PetMed Express Could Climb on a Beat

PetMed Express (PETS - Get Report) is set to report earnings before the open on Monday. We are looking for a nice pop in the stock for a few different reasons.

First, a little background.

The worldwide market for animal health care, excluding bulk feed and nutrition products, is a growing, multibillion-dollar industry. Animal health care is dominated by several large and mega-cap companies, which have distinct operating divisions (from various acquisitions).

Recent press coverage re-affirms this trend is still strong; the American Pet Products Manufacturers Association (APPMA) reported that pet ownership has again reached a new high in 2007. Spending on pets overall and medications in particular are expected to rise in the high-single digits. In a December 2007 article for the Web site Small Business Trends, the CEO of Embrace Pet Insurance predicted that "online veterinary pharmaceuticals will become more mainstream. Pet lovers want, and are demanding, the same treatment options for their pets as they can get for themselves."

With the recent credit panic in the market, it appears that investors must be thinking of PETS as a consumer discretionary stock, lumping it in with PetSmart (PETM) and other struggling retailers.

For starters, as this article is being written, retail sales from Kohl's (KSS - Get Report), Costco (COST - Get Report), J.C. Penney (JCP) and Wal-Mart (WMT - Get Report) are coming in way better than expected. This is also a positive for PetMed. Also, PetSmart, which we feel is not as strong a play as PetMed, has been gaining traction. In fact, a JPMorgan analyst recently upgraded shares of PetSmart, calling the pet products supplier "unpriced, insulated from inflation and poised to benefit from the federal government's economic stimulus package"

PetMed has beaten earnings the past four quarters in a row and eight out of the last 11 quarters. The company has a strong balance sheet: $50 million in cash, zero debt, 60% quarterly earnings growth and 10%-plus profit margins. It is also worth pointing out that PetMed has a mammoth size short-position of 18%, or about 4.1 million shares. For all of the shorts to cover their bearish positions on a climb in stock price, it would take them about 19 days to cover.

We feel there are lots of factors pointing to good things to come for PetMed. We'll see on Monday.
Stockpickr is a wholly owned subsidiary of

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
PETM $82.98 0.04%
COST $163.58 0.00%
JPC $9.20 0.00%
KSS $48.07 0.00%
PETS $16.99 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs